HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endolymphatic Hydrops

An accumulation of ENDOLYMPH in the inner ear (LABYRINTH) leading to buildup of pressure and distortion of intralabyrinthine structures, such as COCHLEA and SEMICIRCULAR CANALS. It is characterized by SENSORINEURAL HEARING LOSS; TINNITUS; and sometimes VERTIGO.
Also Known As:
Hydrops, Endolymphatic
Networked: 541 relevant articles (36 outcomes, 68 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Meniere Disease (Menieres Disease)
2. Vertigo (Positional Vertigo)
3. Syncope (Fainting)
4. Hypertension (High Blood Pressure)
5. Edema (Dropsy)

Experts

1. Naganawa, Shinji: 48 articles (07/2022 - 01/2008)
2. Sone, Michihiko: 43 articles (07/2022 - 01/2008)
3. Nakashima, Tsutomu: 28 articles (03/2017 - 04/2002)
4. Kawai, Hisashi: 19 articles (07/2022 - 01/2010)
5. Yoshida, Tadao: 18 articles (07/2022 - 03/2012)
6. Kitahara, Tadashi: 15 articles (04/2022 - 04/2009)
7. Teranishi, Masaaki: 15 articles (08/2021 - 02/2009)
8. Takeda, Taizo: 15 articles (01/2020 - 07/2002)
9. Kakigi, Akinobu: 13 articles (01/2020 - 07/2002)
10. Yamazaki, Masahiro: 12 articles (01/2014 - 01/2010)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Endolymphatic Hydrops:
1. Glycerol (Glycerine)FDA LinkGeneric
2. GadoliniumIBA
3. Gentamicins (Gentamicin)FDA LinkGeneric
4. Furosemide (Lasix)FDA LinkGeneric
5. Contrast MediaIBA
6. SteroidsIBA
7. IsosorbideFDA Link
8. Dexamethasone (Maxidex)FDA LinkGeneric
9. gadodiamide (Omniscan)FDA Link
10. AldosteroneIBA

Therapies and Procedures

1. Therapeutics
2. Intravenous Administration
3. Intratympanic Injection
4. Intravenous Injections
5. Denervation